Search

everythinglearnresearchcommunity

for

Search:↓

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Dermatologists should consider alpha-gal syndrome in patients with unexplained chronic skin issues.

Certain gene variations may increase the risk of PCOS in South Indian women.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Rapunzel syndrome can show vague symptoms and needs long-term psychiatric care to prevent recurrence.

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

Mosaic Klinefelter syndrome can affect male fertility and may be missed in routine tests.

People with Down syndrome are more likely to experience hair loss, and using dermoscopy can help diagnose it.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Androgen receptor abnormalities may contribute to hair loss in androgenetic alopecia.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Overweight women with PCOS are more likely to have excess male hormones.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Metformin helps manage PCOS by improving fertility and is safe for pregnancy, especially when combined with certain treatments.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.